STOCK TITAN
  1. Home
  2. Sec-filings
  3. XGN
  4. [EFFECT] Exagen Inc. SEC Filing

[EFFECT] Exagen Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 2, 2025 4:01 P.M.
Form: S-3
CIK: 0001274737
Company Name: EXAGEN INC.
File Number: 333-288199

Source: View Original Filing on SEC EDGAR

Exagen Inc.

NASDAQ:XGN

View XGN Stock Overview →

XGN Rankings

#5313 Ranked by Market Cap
N/A Ranked by Dividends

XGN Latest News

Mar 10, 2026
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
Mar 3, 2026
Exagen Inc. to Participate in Upcoming Investor Conferences
Feb 24, 2026
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
Jan 11, 2026
Exagen Inc. Announces Select Preliminary 2025 Financial Results
Nov 11, 2025
Exagen Inc. to Participate in Fourth Quarter Investor Conferences

XGN Latest SEC Filings

Mar 10, 2026
[8-K] EXAGEN INC. Reports Material Event
Mar 4, 2026
[Form 4] EXAGEN INC. Insider Trading Activity
Feb 25, 2026
[Form 4] EXAGEN INC. Insider Trading Activity
Feb 25, 2026
[Form 4] EXAGEN INC. Insider Trading Activity
Feb 17, 2026
[SCHEDULE 13G/A] EXAGEN INC. Amended Passive Investment Disclosure

XGN Stock Data

74.56M
15.01M
Diagnostics & Research
Services-medical Laboratories
Link
United States
VISTA